Sinopharm Holdings' subsidiary, SINOPHARM (CNCM LTD), reported a slight decrease in net profit to 459 million RMB in the first quarter
Sinopharm Holdings (01099.HK) announced that its subsidiary Sinopharm (600511.SH) reported a first-quarter revenue of RMB 12.713 billion, an increase of 4.9% year-on-year. The net profit attributable to shareholders was RMB 459 million, a slight decline of 0.1%, with earnings per share of 60.84 cents
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments